CJC-1295 (NO DAC) 5mg

CJC-1295 — Overview

CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH). Research versions are typically studied as tetra-substituted GHRH(1–29) analogs, with or without a Drug Affinity Complex (DAC) modification, to investigate peptide half-life, receptor engagement, and growth-hormone axis signaling in experimental models.

Background & Research Interest

Common laboratory topics include:

• GHRH receptor binding and downstream signaling
• Effect of amino-acid substitutions on peptide stability
• Comparison of DAC and non-DAC (Mod GRF 1–29) constructs
• Peptide characterization, impurity profiling, and aggregation behavior

General Characteristics

• Peptide type: Synthetic GHRH analog
• Forms studied: With DAC or without DAC (Mod GRF 1–29)
• Typical research form: Lyophilized powder
• Analytical focus: Sequence confirmation, purity, and related-substance profiling

For research and laboratory use only. Not for human consumption. Not an FDA-approved drug.